全文获取类型
收费全文 | 6275篇 |
免费 | 1399篇 |
国内免费 | 249篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 243篇 |
妇产科学 | 116篇 |
基础医学 | 778篇 |
口腔科学 | 219篇 |
临床医学 | 882篇 |
内科学 | 1484篇 |
皮肤病学 | 98篇 |
神经病学 | 689篇 |
特种医学 | 120篇 |
外国民族医学 | 1篇 |
外科学 | 692篇 |
综合类 | 588篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 465篇 |
眼科学 | 106篇 |
药学 | 503篇 |
7篇 | |
中国医学 | 111篇 |
肿瘤学 | 756篇 |
出版年
2024年 | 24篇 |
2023年 | 176篇 |
2022年 | 386篇 |
2021年 | 532篇 |
2020年 | 497篇 |
2019年 | 520篇 |
2018年 | 443篇 |
2017年 | 457篇 |
2016年 | 453篇 |
2015年 | 423篇 |
2014年 | 488篇 |
2013年 | 497篇 |
2012年 | 347篇 |
2011年 | 344篇 |
2010年 | 263篇 |
2009年 | 223篇 |
2008年 | 215篇 |
2007年 | 181篇 |
2006年 | 192篇 |
2005年 | 158篇 |
2004年 | 150篇 |
2003年 | 127篇 |
2002年 | 120篇 |
2001年 | 105篇 |
2000年 | 82篇 |
1999年 | 67篇 |
1998年 | 60篇 |
1997年 | 48篇 |
1996年 | 31篇 |
1995年 | 36篇 |
1994年 | 34篇 |
1993年 | 24篇 |
1992年 | 26篇 |
1991年 | 16篇 |
1990年 | 21篇 |
1989年 | 12篇 |
1988年 | 8篇 |
1987年 | 9篇 |
1986年 | 16篇 |
1985年 | 21篇 |
1984年 | 16篇 |
1983年 | 19篇 |
1982年 | 14篇 |
1981年 | 12篇 |
1980年 | 8篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1969年 | 2篇 |
排序方式: 共有7923条查询结果,搜索用时 15 毫秒
41.
目的 探讨血清长链非编码RNA(lncRNA)FOXD2-AS1、含铜胺氧化酶4的假基因(AOC4P)的相对表达水平,以及与肿瘤标志物癌胚抗原(CEA)、糖类抗原(CA)199、CA724的联合检测在胃癌(GC)诊断中的临床应用价值。方法 收集该院80例GC患者和85例年龄相仿的体检健康者的血清以及16组GC组织与癌旁组织。利用TCGA数组库分析FOXD2-AS1在GC及癌旁组织中的表达;应用实时荧光定量聚合酶链反应(qRT-PCR)方法检测组织AOC4P,以及血清FOXD2-AS1、AOC4P的相对表达量;化学发光法检测血清CEA、CA199、CA724的水平。应用受试者工作特征(ROC)曲线评价FOXD2-AS1、AOC4P单独诊断以及其与CEA、CA199、CA724联合检测对GC的诊断效能。结果 初诊GC患者血清FOXD2-AS1、AOC4P相对表达量升高,且显著高于健康对照者,差异有统计学意义(P<0.01)。ROC曲线分析结果显示,FOXD2-AS1、AOC4P、CEA、CA199和CA724的曲线下面积(AUC)分别为0.879、0.856、0.699、0.654和... 相似文献
42.
BackgroundtRNA‐derived fragments (tRFs) have been found to have a crucial function in the pathophysiology of cancers. However, the function of tRFs in non‐small cell lung cancer (NSCLC) is yet unknown. The goal of this study was to assess the tRF‐31‐79MP9P9NH57SD serum expression from NSCLC patients and to determine its diagnostic usefulness.MethodsBy using stem‐loop quantitative real‐time PCR, we were able to detect various tRF‐31‐79MP9P9NH57SD expressions in 96 NSCLC serum samples, 96 healthy controls, and 20 pairs of NSCLC serum samples pre‐ and post‐surgery (qRT‐PCR). After that, we analyzed its diagnostic effectiveness using the receiver operating characteristic (ROC) curve.ResultsSerum tRF‐31‐79MP9P9NH57SD expression was higher in NSCLC patients, and levels of tRF‐31‐79MP9P9NH57SD were linked to the clinical stage (p = 0.002) and the malignancy of lymph node (p = 0.012). In addition, after the procedure, the serum tRF‐31‐79MP9P9NH57SD expression in NSCLC patients dropped. With 48.96 percent sensitivity and 90.62 percent specificity, the area under ROC curve (AUC) was 0.733.Conclusionserum tRF‐31‐79MP9P9NH57SD possibly is a new and groundbreaking biomarker for the NSCLC. 相似文献
43.
44.
Qi-Wei Wang Jing Li Xiao-Shan Lin Wan Chen Qiao-Lin Zhu Feng-Qi Zhou Hao-Tian Lin Wei-Rong Chen 《国际眼科》2022,15(1):65-70
AIM:To assess the effectiveness of core vitrectomyphacoemulsification-intraocular lens(IOL)implantationcapsulo-hyaloidotomy in treating phakic eye at least 1 mo after the onset of malignant glaucoma.METHODS:A retrospective analysis were performed on malignant glaucoma patients treated in Zhongshan Ophthalmic Center between 2016 and 2018.Demographic and clinical data were described.The preoperative and postoperative visual acuity(VA),intraocular pressure(IOP),number of IOP-lowering medications used,and anterior chamber depth(ACD)of the case series were compared by Wilcoxon signed-rank test.RESULTS:Thirteen phakic eyes with long time intervals between onset and surgery were identified in this case series.Core vitrectomy-phacoemulsification-IOL implantation-capsulohyaloidotomy reduced the IOP(P=0.046)and the number of IOP-lowering medications used(P=0.004),deepened the ACD(P=0.005).Complete success was achieved in 38.5%of the eyes,and anatomical success was achieved in 100%of the eyes without any recurrence.The only postoperative complication observed is corneal endothelial decompensation.It occurred in two cases.CONCLUSION:Core vitrectomy-phacoemulsification-IOL implantation-capsulo-hyaloidotomy is safe and effective for treatment of long onset phakic malignant glaucoma. 相似文献
45.
Huang Z Dias R Jones T Liu S Styhler A Claveau D Otu F Ng K Laliberte F Zhang L Goetghebeur P Abraham WM Macdonald D Dubé D Gallant M Lacombe P Girard Y Young RN Turner MJ Nicholson DW Mancini JA 《Biochemical pharmacology》2007,73(12):1971-1981
Type 4 phosphodiesterases (PDE4) inhibitors are emerging therapeutics in the treatment of a number of chronic disorders including asthma, chronic obstructive pulmonary disease (COPD) and cognitive disorders. This study delineates the preclinical profile of L-454,560, which is a potent, competitive and preferential inhibitor of PDE4A, 4B, and 4D with IC50 values of 1.6, 0.5 and 1.2 nM, respectively. In contrast to the exclusive binding of cilomilast and the preferential binding of roflumilast to the PDE4 holoenzyme state (Mg2+-bound form), L-454,560 binds to both the apo-(Mg2+-free) and holoenzyme states of PDE4. The intrinsic enzyme potency for PDE4 inhibition by L-454,560 also results in an effective blockade of LPS-induced TNFalpha formation in whole blood (IC50 = 161 nM) and is comparable to the human whole blood potency of roflumilast. The cytokine profile of inhibition of L-454,560 is mainly a Th1 profile with significant inhibition of IFNgamma and no detectable inhibition of IL-13 formation up to 1 microM. L-454,560 was also found to be efficacious in two models of airway hyper-reactivity, the ovalbumin (OVA) sensitized and challenged guinea pig and the ascaris sensitized sheep model. Furthermore, L-454560 was also effective in improving performance in the delayed matching to position (DMTP) version of the Morris watermaze, at a dose removed from that associated with potential emesis. Therefore, L-454,560 is a novel PDE4 inhibitor with an overall in vivo efficacy profile at least comparable to roflumilast and clearly superior to cilomilast. 相似文献
46.
目的:评价铺灸疗法治疗强直性脊柱炎(AnkylOSingSpondylitiS,AS)疗效的优越性、远期疗效及安全性。方法:计算机检索从2000年到2012年在中国知网(CNKI)、万方数据库(WF)中收录的有关铺灸疗法为主治疗AS的随机对照试验(randomizedcontrolledtrial,RCT)文献,对文献进行质量评价,并用ReviewManager5.1软件进行荟萃分析(Meta分析)。结果:总共纳入临床随机对照试验文献17篇,涉及患者共1700名。Meta分析结果显示铺灸疗法治疗强直性脊柱炎的总体有效率优于口服西药疗法和单纯针刺疗法。与口服西药疗法比较,合并后效应指标RR=I.24,95%(ConfidenceInterval,CI)为(1.14,1.35);与针刺疗法比较,合并后效应指标RR=I.27,95%CI(1.05,1.53)。结论:此次纳入研究丈献质量普遍偏低:全部为单中心RCT研究,无多中心研究。其次,随机分组方法不够准确,多数文献未描述随访、脱落、远期疗效情况,诊断标准、疗效评价指标种类繁多,未能采取国际公认的标准。与口服西药疗法比较,铺灸疗法的总体有效率远高于12服西药疗法,疗效优越且复发率较低,无毒副作用,安全可靠;和针刺疗法比较,虽然药物铺灸疗法总体有效率较高,由于纳入研究数目较少,总病例数亦少,无远期疗效和安全性方面对比,其结果有待于大样本、多中心、方法科学的高质量临床研究加以验证。 相似文献
47.
长链非编码 RNA(lncRNA)可在遗传水平、转录水平、转录后水平等多层面上通过多种机制调控基因表达,参与生理、病理过程,与多种人类重大疾病关系密切。 lncRNA 在造血细胞成熟、分化过程中也起重要的调控作用,深入探索其作用机制可为血液疾病的诊治提供新思路。 相似文献
48.
目的:通过鉴定与肺腺癌(LUAD)预后相关的长非编码RNA(lncRNA),研究LUAD的发生机制及其预后意义,确定与LUAD预后相关的敏感性生物标志物,并对其进行免疫途径相关性分析。方法:从肿瘤基因组图谱数据库(TCGA)中获取与LUAD相关的数据,通过单因素Cox回归分析及套索算法(LASSO)筛选lncRNA,使用多因素Cox回归进行预后风险评分分析,建立预后风险模型,用计算曲线下面积(AUC)和Kaplan-Meier(K-M)生存分析方法评价模型的稳健性和准确性。利用K-M生存分析方法确定与生存状态相关的潜在生物标志物,并通过ImmLnc平台对其进行免疫途径相关性研究。结果:从49个与生存相关的lncRNAs中确定了12个预后相关生物标志物,通过K-M生存分析,MIR34AHG和PRKCA-AS1被确定为与预后相关的生物标志物(P<0.05)。模型的3年和5年生存率的AUC分别为0.82和0.846。与MIR34AHG相关的免疫途径分别为“细胞因子受体”(P<0.05),“抗原处理和提呈”(P<0.05),与PRKCA-AS1相关的免疫途径为“抗原处理和提呈”(P<0.05)。结论:通过对生物信息大数据的分析,我们确定了两个关键lncRNAs及其相关的免疫途径,为LUAD的预后评估提供了新的生物标志物。 相似文献
49.
Chrubasik C Wiesner L Black A Müller-Ladner U Chrubasik S 《Phytotherapy research : PTR》2008,22(9):1141-1148
This pilot surveillance included 152 patients with acute exacerbations of chronic pain, 124 (Back group) with non-specific low back pain (NSLBP), 20 with NSLBP overridden by osteoarthritic pain (Knee-Hip group), and eight with specific LBP (included in the safety analysis). Patients were recommended the rose hip and seed powder Litozin at a dose providing up to 3 mg of galactolipid/day for up to 54 weeks. Clinical symptoms and well-being were assessed every 6 weeks. The patients also kept a diary of their pain and the requirement for rescue medication. Data were analysed by intention to treat with last observation carried forward. Only 77 patients completed the year of surveillance. Multivariate analysis suggested an appreciable overall improvement during the surveillance, irrespective of group, and this was reflected for most of the individual measures in repeated measures ANOVA. The degree and time-course of improvement echoed that seen in similar surveillances of patients receiving an aqueous extract of Harpagophytum. Multiple regression analyses indicated that percentage changes from baseline tended to be greater in patients with greater degrees of pain and disability, but were otherwise largely unrelated to the patients' characteristics. There were no serious adverse events. The rose hip and seed powder, Litozin, seems to deserve further, more definitive studies as a possible option in long-term management of NSLBP with or without osteoarthritic pain. 相似文献
50.